로딩 중…
지수 로딩 중…
Dyne Therapeutics, Inc.
DYN· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$18.06+4.33%
2026-09-17
Financials
Valuation Metrics
Dyne Therapeutics, Inc.'s Market Cap is $3.37B. At end of 2025 it was $2.51B. Ranked #1644 of 3,121 in US market (top 53%), #583 of 1,463 on NASDAQ (top 40%), #99 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 37%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $3.37B | US#1,644/3,121 Sec#99/266 |
| Revenue | $0.00 | US#2,889/3,121 Sec#196/266 |
| Net Income | $-519M | US—/3,121 Sec—/266 |
| Total Assets | $994M | US#2,486/3,121 Sec#104/266 |
| Net Assets | $702M | US#2,010/3,121 Sec#87/266 |
| Value | ||
| P/B | 4.80x | US#2,194/3,121 Sec#138/266 |
| FCF Yield | -14.80% | US—/3,121 Sec—/266 |
| Profitability | ||
| ROE | -73.97% | US#2,762/3,121 Sec#192/266 |
| ROA | -52.25% | US#2,997/3,121 Sec#217/266 |
| Financial Health | ||
| Debt Ratio | 41.57% | US#473/3,121 Sec#132/266 |
| Total Debt | $20M | US#2,762/3,121 Sec#191/266 |
| FCF | $-499M | US#2,909/3,121 Sec#254/266 |
| Cash | $676M | US#883/3,121 Sec#41/266 |
| Current Ratio | 12.02x | US#210/3,121 Sec#65/266 |
| Performance | ||
| 1Y Return | 37.34% | US#759/3,121 Sec#125/266 |
| 1M Return | -30.54% | US#3,077/3,121 Sec#262/266 |
| From 52W High | -33.87% | US#2,251/3,121 Sec#175/266 |
| 1Y MDD | -39.89% | US#2,009/3,121 Sec#140/266 |
| Trading | ||
| Volume | 2,808,311 shares | US#628/3,121 Sec#60/266 |
| Trading Value | $50M | US#1,257/3,121 Sec#94/266 |
| Per Share | ||
| EPS | $-2.78 | US—/3,121 Sec—/266 |
| BPS | $3.76 | US#2,391/3,121 Sec#146/266 |